CORI Quote, Trading Chart, Corium International Inc.
home / stock / cori / cori quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2018-11-26 | 12.67 | 12.68 | 12.745 | 12.65 | 4,072,230 |
| 2018-11-23 | 12.66 | 12.65 | 12.68 | 12.64 | 598,882 |
| 2018-11-21 | 12.67 | 12.71 | 12.71 | 12.64 | 377,910 |
| 2018-11-20 | 12.68 | 12.67 | 12.68 | 12.64 | 427,780 |
| 2018-11-19 | 12.65 | 12.67 | 12.69 | 12.65 | 221,549 |
| 2018-11-16 | 12.62 | 12.65 | 12.66 | 12.62 | 439,205 |
| 2018-11-15 | 12.62 | 12.63 | 12.66 | 12.62 | 344,620 |
| 2018-11-14 | 12.62 | 12.64 | 12.65 | 12.62 | 188,697 |
| 2018-11-13 | 12.61 | 12.64 | 12.64 | 12.61 | 204,907 |
| 2018-11-12 | 12.60 | 12.60 | 12.62 | 12.59 | 516,613 |
| 2018-11-09 | 12.61 | 12.60 | 12.63 | 12.60 | 493,754 |
| 2018-11-08 | 12.60 | 12.61 | 12.62 | 12.59 | 370,929 |
| 2018-11-07 | 12.61 | 12.61 | 12.63 | 12.59 | 589,244 |
| 2018-11-06 | 12.59 | 12.60 | 12.61 | 12.59 | 441,204 |
| 2018-11-05 | 12.60 | 12.60 | 12.61 | 12.58 | 433,159 |
| 2018-11-02 | 12.63 | 12.59 | 12.63 | 12.58 | 608,770 |
| 2018-11-01 | 12.64 | 12.61 | 12.68 | 12.58 | 691,694 |
| 2018-10-31 | 12.62 | 12.65 | 12.66 | 12.60 | 533,319 |
| 2018-10-30 | 12.61 | 12.60 | 12.63 | 12.58 | 562,848 |
| 2018-10-29 | 12.63 | 12.61 | 12.67 | 12.57 | 503,741 |
Corium International Inc. Company Name:
CORI Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
-
MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
-
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
-
MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...